CHRONIC GOUT
Clinical trials for CHRONIC GOUT explained in plain language.
Never miss a new study
Get alerted when new CHRONIC GOUT trials appear
Sign up with your email to follow new studies for CHRONIC GOUT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New gout drug shows promise in lowering uric acid levels
Disease control CompletedThis study tested an experimental drug called SEL-212 in 112 adults with chronic gout that standard treatments couldn't control. Participants received one of two doses of SEL-212 or a placebo every 28 days for about 6 months. The main goal was to see if SEL-212 could lower and ke…
Matched conditions: CHRONIC GOUT
Phase: PHASE3 • Sponsor: Swedish Orphan Biovitrum • Aim: Disease control
Last updated May 26, 2026 07:29 UTC
-
New gout drug shows promise in lowering uric acid levels
Disease control CompletedThis study tested a new medicine called SEL-212 in 153 adults with chronic gout that did not get better with standard treatments. The goal was to see if SEL-212 could safely lower uric acid levels below a target threshold for at least 80% of the time over six months. Participants…
Matched conditions: CHRONIC GOUT
Phase: PHASE3 • Sponsor: Swedish Orphan Biovitrum • Aim: Disease control
Last updated May 26, 2026 07:19 UTC
-
New combo therapy offers hope for severe gout sufferers
Disease control CompletedThis study tested a gout medication called KRYSTEXXA given every 4 weeks along with weekly methotrexate in 50 adults with severe gout that didn't respond to standard treatments. The goal was to see if this combination could lower uric acid levels and be safe. The results help gui…
Matched conditions: CHRONIC GOUT
Phase: PHASE4 • Sponsor: Amgen • Aim: Disease control
Last updated May 19, 2026 12:01 UTC